Historical record - last NADAC effective date: 1/5/2018
Product Information
EMEND TRIPACK is a brand product labeled by Merck Sharp & Dohme LLC, priced at $246.0190 per EA under NDC 00006386203. Its NADAC has been published 269 times since Nov 28, 2013.
FDA first approved this application on Mar 26, 2003. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the aprepitant market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Manufacturer
Merck Sharp & Dohme LLCNDC
00006386203
Classification
Brand
Dosage Form
KIT
Effective Date
1/5/2018
Approval Type
New Drug (NDA)
FDA Application
NDA021549FDA Approved
3/26/2003
TE Code
AB
On Market Since
3/26/2003
Price Statistics
The NADAC for EMEND TRIPACK has been published 269 times since Nov 28, 2013, and over the history we have for it it has risen 87.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $246.0190 per EA |
|---|---|
| All-time high | $246.0190 (Jan 16, 2019) |
| All-time low | $131.1518 (Nov 28, 2013) |
| Median price | $189.9350 |
| Average price | $193.8030 |
| Largest weekly change | +9.9% (Jan 17, 2018) |
| Weeks tracked | 269 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+87.6%
Last surveyed Jan 16, 2019 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 65% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of EMEND TRIPACK?
The current National Average Drug Acquisition Cost (NADAC) for EMEND TRIPACK, manufactured by Merck Sharp & Dohme LLC, is $246.0190 per EA (NDC 00006386203), effective Jan 16, 2019.
How has the price of EMEND TRIPACK changed over time?
Over the history we have for it, the NADAC for EMEND TRIPACK has risen 87.6%. It has been tracked across 269 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for EMEND TRIPACK?
Since Nov 28, 2013, the NADAC for EMEND TRIPACK has ranged from a low of $131.1518 (Nov 28, 2013) to a high of $246.0190 (Jan 16, 2019), with a median of $189.9350 per EA.
Are there cheaper alternatives to EMEND TRIPACK?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, APREPITANT 125-80-80 MG PACK, is $87.2662 per EA — about 65% below EMEND TRIPACK.
Who manufactures EMEND TRIPACK?
EMEND TRIPACK (NDC 00006386203) is labeled by Merck Sharp & Dohme LLC, and CMS classifies it as a brand product.